Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Peripheral neuropathy assessment in oxaliplatin, paclitaxel, and nab-paclitaxel chemotherapy using nerve conduction and vibration tests
jRCT1070210108Active, not recruiting
- Sponsor
- Takashi Inagaki
- Start
- May 2018
- Modality
- Small Molecules, DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Open-label trial of oxaliplatin and paclitaxel in esophageal cancer, gastric cancer (GC), colorectal cancer (CRC) and 1 more (3 arms), sponsored by Takashi Inagaki. Started May 2018; status: active, not recruiting.
02
Drugs
oxaliplatinpaclitaxel
03
Conditions
esophageal cancergastric cancer (GC)colorectal cancer (CRC)pancreatic cancer (PC)
Beyond the preview
Go deeper on jRCT1070210108.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1070210108.